Antibody-drug conjugates (ADCs) have become a promising targeted therapy strategy that combines the specificity, favorable pharmacokinetics and biodistributions of antibodies with the destructive potential of highly potent drugs. One of the biggest challenges in the development of ADCs is the application of suitable linkers for conjugating drugs to antibodies. Recently, the design and synthesis of linkers are making great progress. In this review, we present the methods that are currently used to synthesize antibody-drug conjugates by using thiols, amines, alcohols, aldehydes and azides.
Yao, H., Jiang, F., Lu, A., & Zhang, G. (2016, February 2). Methods to design and synthesize antibody-drug conjugates (ADCs). International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms17020194